SOURCE: CV Sciences, Inc.

September 01, 2016 09:00 ET

CV Sciences, Inc. to Present at the 18th Annual Rodman & Renshaw Global Investment Conference

LAS VEGAS, NV--(Marketwired - September 01, 2016) - CV Sciences, Inc. (OTCBB: CVSI) (the "Company", "CV Sciences", "our" or "we"), announced today that it will be presenting at the 18th Annual Rodman & Renshaw Global Investment Conference being held September 11-13, 2016 at the Lotte New York Palace Hotel, New York City.

Event: 18th Annual Rodman & Renshaw Global Investment Conference

Location: Lotte New York Palace Hotel, New York, NY

Date: Tuesday, September 13, 2016

Time: 4:40 PM ET in Holmes I Room (4th Floor)

A live webcast will be available at: http://wsw.com/webcast/rrshq26/cvsi. CV Sciences Chairman and CEO Michael Mona, Jr. and Chief Financial Officer Joseph Dowling will present an overview of the Company and discuss its recent business highlights. Management will also be available for one-on-one meetings. To arrange a one-on-one meeting with management, please visit this link or contact Robert Haag at cvsi@irthcommunications.com.

About Rodman & Renshaw Conferences, LLC

The Rodman & Renshaw 18th Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC, is being held on September 11 - 13, 2016 at the Lotte New York Palace Hotel in New York City. Approximately 300 companies will be presenting their businesses to an audience of approximately 2,000 attendees. The conference will focus on tracks dedicated to Healthcare; Natural Resources; Technology; Media and telecommunications; and Cleantech. This year's conference will bring growth companies together with a vast audience and strategic investors. In addition to corporate presentations, Rodman facilitates one-on-one investor meetings and provides platforms for engaged Q&A sessions and daily networking opportunities.

About CV Sciences, Inc.

CV Sciences, Inc. (OTCBB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division in manufacturing, marketing and selling plant-based CBD products to a range of market sectors. CV Sciences, Inc. has primary offices and facilities in Las Vegas, Nevada and San Diego, California. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Contact Information